OpenAI's Video App Can't Use 'Cameo' As TM Case Proceeds

Tuesday, February 17, 2026iiplaeditorialSource: IIPLA
openai-s-video-app-can-t-use-cameo-as-tm.png
Source attribution
Image: Image courtesy of iipla.org

OpenAI's Video App Can't Use 'Cameo' As TM Case Proceeds

By Editorial Team

A California federal judge has issued a preliminary injunction blocking OpenAI from using the word "Cameo" to refer to a component of its Sora AI video generator app. This decision comes in response to litigation brought by a personalized video provider of the same name, which argued that its consumer reputation was threatened by the artificial intelligence company.

The case, which is being heard in the U.S. District Court for the Northern District of California, involves OpenAI OpCo LLC and Reddit Inc. as the companies in question. The legal teams representing the parties include Byron Raphael LLP and Quinn Emanuel.

OpenAI's use of the term "Cameo" has sparked a trademark dispute, leading to the court's decision to issue the preliminary injunction. The case is ongoing, and further developments are expected as the legal proceedings continue.

This ruling highlights the importance of protecting intellectual property rights and the potential conflicts that can arise in the technology and entertainment industries. As the case progresses, it will be crucial to monitor how the court addresses the trademark dispute between OpenAI and the personalized video provider.

Related Coverage

Continue in the newsroom

Back to newsroom
IP News

Purple Rain Co-Star Ends Apollonia Trademark Rights Suit

‘Purple Rain’ Co-Star Ends ‘Apollonia’ Trademark Rights Suit By Editorial Team Patty Apollonia Kotero, known for her role as Prince’s co-star in the iconic 1984 film “Purple Rain,” has decided to drop her lawsuit agai...

Thursday, April 9, 2026
IP News

Federal Circuit Grills Sanctioned Patent Lawyer Over Conduct

Federal Circuit Grills Sanctioned Patent Lawyer Over Conduct By Editorial Team A Houston-based patent attorney faced a tough Federal Circuit bench while seeking to wipe out a $207,000 sanction against him and his clie...

Thursday, April 9, 2026
IP News

J&J Defends Blood-Clotting Powder IP From Baxter Attack

J&J Defends Blood-Clotting Powder IP From Baxter Attack By Editorial Team A subsidiary of Johnson & Johnson has successfully defended its patent for a hemostatic powder used to treat bleeding against objections from B...

Thursday, April 9, 2026